Study S003221

A First in Human, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Dose of ZP7570 in Healthy Subjects

ClinicalTrials.gov record

Registration

Registration: NCT03994549
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: EARLY_PHASE1
Masking: TRIPLE
Status: COMPLETED
Enrollment: 64
Start: 2019-06-14
Primary completion: 2020-11-02
Lead sponsor: Zealand Pharma
Conditions: Healthy
Interventions: DRUG:Dual GLP-1/GLP-2 Receptor agonists
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: EUDRACT_NUMBER:2019-001128-36; NIH:2019

Registered primary outcomes

Safety - Incidence of adverse events (AEs) [From time zero to 28 days after dosing]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.